2012 ACR/ARHP Annual Meeting Archives - Page 180 of 180

Abstract Number: 2595

S100A12 At Baseline May Be Useful for Predicting Inactive Disease within 12 Months in Polyarticular Juvenile Idiopathic Arthritis
Abstract Number: 530

S100A8/A9 Is Upregulated and Triggers the Secretion of Pro-Inflammatory Cytokines in Primary Sjögren’s Syndrome
Abstract Number: 1678

Safety and Efficacy of Adalimumab in Children with Active Polyarticular Juvenile Idiopathic Arthritis Aged 2 to <4 Years or ≥4 Years Weighing <15 Kg
Abstract Number: 2031

Safety and Efficacy of Anakinra in Patients with Deficiency of Interleukin-1 Receptor Antagonist
Abstract Number: 1997

Safety and Efficacy of Denosumab Vs Ibandronate in Postmenopausal Women Sub-Optimally Treated with Daily or Weekly Bisphosphonates: A Randomized, Open-Label Study
Abstract Number: 639

Safety and Efficacy of Epratuzumab in an Open-Label Extension Study (SL0006)
Abstract Number: 1432

Safety and Efficacy of Etanercept in Systemic LUPUS Erythematosus
Abstract Number: 1677

Safety and Efficacy of Intra-Articular Infliximab Therapy for Treatment Resistant Temporomandibular Joint Arthritis in Children
Abstract Number: 502

Safety and Efficacy of Rituximab in Patients with Rheumatoid Arthritis and Lung Involvement
Abstract Number: 1895

Safety Competences Knowledge and Behavioural Skills of Patients Treated by Biologics in Rheumatology
Abstract Number: 356

Safety of Abatacept in Rheumatoid Arthritis with Chronic Hepatitis B VIRUS Infection
Abstract Number: 180

Safety of Canakinumab in a Large Cohort of Patients with Cryopyrin-Associated Periodic Syndrome: Results From the ß-Confident Registry
Abstract Number: 1141

Safety of Celecoxib and Non-Selective Non-Steroidal Anti-Inflammatory Drugs in Juvenile Idiopathic Arthritis
Abstract Number: 2054

Safety of Joint and Soft Tissue Injections in Patients On Warfarin Anti-Coagulation
Abstract Number: 2187

Safety of Minor Labial Salivary Gland Biopsy
Abstract Number: 503

Safety Update On Certolizumab Pegol in Patients with Active Rheumatoid Arthritis with Long Term Exposure
Abstract Number: 196

Sarcoidosis in Northern New England. Clinical Characteristics and Predictive Factors for More Aggressive Therapy
Abstract Number: 1320

Sarilumab, a Subcutaneously-Administered, Fully-Human Monoclonal Antibody Inhibitor of the IL-6 Receptor: Effects On Hemoglobin Levels in a Clinical Trial for the Treatment of Moderate-to-Severe Rheumatoid Arthritis
Abstract Number: 1337

Sarilumab, a Subcutaneously-Administered, Fully-Human Monoclonal Antibody Inhibitor of the IL-6 Receptor: Pharmacokinetic Profile and Its Relationship to Changes in Pharmacodynamic Markers in Patients with Rheumatoid Arthritis
Abstract Number: 346

Sclerostin Protects Against Inflammatory Bone Loss by Regulating Tnfalpha Mediated p38-Mapkinase Activation
Abstract Number: 1023

Scoring Radiographic Progression in Axial Spa: Should We Use the Modified Stoke in Ankylosing Spondylitis Spine Score or the Radiographic Ankylosing Spondylitis Spinal Score?
Abstract Number: 2442

Screening of Osteoporosis in Men Age 70 and Older: A Need for Increased Awareness
Abstract Number: 39

SDF-1 Induces Osteoclastogenesis in Rheumatoid Arthritis by Upregulating of RANKL Expression in Synovial Fibroblasts and CD4+ T Cells
Abstract Number: 1055

Sec61 Is Indispensable for Antigen Cross-Presentation and the Development of Lupus Nephritis: A Novel ‘Self-Organized Criticality Theory’ Explaining the Cause of Systemic Lupus Erythematosus (SLE)
Abstract Number: 2191

Secretagogue Use in Patients with Primary Sjogren’s Syndrome
Abstract Number: 2302

Secreted Frizzled-Related Protein 4 Induces a Profibrotic Phenotype in Systemic Sclerosis Fibroblasts by Activating a Non-Canonical WNT Signaling Pathway
Abstract Number: 443

Secreted Frizzled-Related Protein 5 Exerts the Anti-Inflammatory Role in Rheumatoid Arthritis Via Down-Regulation of c-Jun N-Terminal Kinase
Abstract Number: 919

Sedentary Time, Physical Activity, and Concurrent Blood Pressure in Osteoarthritis Initiative Participants
Abstract Number: 1008

Segmentation and Quantification of Bone Erosions in the Hands of Patients with Rheumatoid Arthritis Using High Resolution Computed Tomography
Abstract Number: 740

Select Soluble Inflammatory Mediators Are Detected Prior to and Increase At Systemic Lupus Erythematosus Classification
Abstract Number: 334

Selective iNOS Inhibition Increases the Lymphatic Pulse and Drainage From Arthritic Joints in TNF-Tg Mice
Abstract Number: 2489

Selective JAK1 Inhibition in the Treatment of Rheumatoid Arthritis: Proof of Concept with GLPG0634
Abstract Number: 1225

Self Reported Comorbidity Is Common in Early Inflammatory Arthritis and Associated with Poorer Function and Quality of Life and Greater Disease Activity: Results From the Canadian Early Arthritis Cohort
Abstract Number: 946

Self-Reported Disease Activity and Health-Related Quality of Life in a Longitudinal Cohort of Patients with Systemic Lupus Erythematosus
Abstract Number: 1746

Semaphorin 3A Increases the Regulatory Characteristics of B-Regulatory Cells
Abstract Number: 1028

Semi-Quantitative Assessment of Bone Marrow Edema and Synovitis-Effusion in Osteoarthritis with the Knee Inflammation MRI Scoring System: A Target Lesion Based Methodology
Abstract Number: 2312

Senescent T Cells Promote Bone Loss in Rheumatoid Arthritis
Abstract Number: 107

Sensitivity to Change of the Ultrasound synovitis SONAR Score in RA Patients : Results of the Scqm Cohort
Abstract Number: 657

Serial Screening Shows That 28% of Systemic Lupus Erythematosus Adult Patients Carry an Underlying Primary Immunodeficiency
Abstract Number: 467

Seropositive Rheumatoid Arthritis Patients with an Inadequate Response to Tumor Necrosis Factor Inhibitors Achieve Improved Clinical Effectiveness After Switching to Rituximab Versus Switching to an Alternative Tumor Necrosis Factor Inhibitor
Abstract Number: 2465

Seroresponse Rates After Influenza Vaccination in Rheumatoid Arthritis Patients Treated with Biological Agents During the 2011–2012 Flu Season
Abstract Number: 2014

Serum 25(OH)D Levels in Adolescents and Young Adults with Juvenile Idiopathic Arthritis and Juvenile Onset Systemic Lupus Erythematosus: Prevalence and Association with Disease Activity
Abstract Number: 43

Serum Amyloid A Level in Knee Osteoarthritis: Systemic and/or Local Production and Pro-Inflammatory Properties On Human Chondrocytes and Fibroblast-Like Synoviocytes
Abstract Number: 1532

Serum Angiopoietin-2 Level Reflects the Disease Activity and Renal Function in Antineutrophilic Cytoplasmic Antibody-Associated Vasculitis
Abstract Number: 669

Serum Anti N-Methyl-D-Aspartate Receptor Subunit 1 Antibodies Are Elevated in SLE
Abstract Number: 1240

Serum Anti-Müllerian Hormone Can Be Used to Determine Ovarian Reserve in Women with Rheumatoid Arthritis
Abstract Number: 1758

Serum BAFF Levels and Relationship with BAFF Binding Receptors in Patients with Rheumatoid Arthritis Relapsing After B Cell Depletion Therapy
Abstract Number: 2167

Serum Based Biomarkers of Joint Destruction Can Identify Responders and Non-Responder to Tocilizumab
Abstract Number: 1623

Serum Biomarkers Signature Identifies Patients with Overt B-Cell Non-Hodgkin Lymphoma Associated with Mixed Cryoglobulinemia in Chronic HCV Infection
Abstract Number: 2124

Serum Concentrations of Soluble Interferon Receptor in Patients with Rheumatoid Arthritis
Abstract Number: 1269

Serum Cytokines Associated with Carotid Atherosclerosis in Rheumatoid Arthritis
Abstract Number: 2260

Serum DNAse I Anti DNAse I Antibodies , CRP and Antibodies to CRP Relation to Disease Activity in Systemic Lupus Eryhtematous: Longitudinal Studies
Abstract Number: 1809

Serum IFNα Activity in Systemic Lupus Erythematosus Drops in Response to Immunosuppressive Therapy Only When There Is Concurrent Clinical Response
Abstract Number: 65

Serum Inflammatory Biomarkers Correlated Stronger with a Panel of Serum Steroid and Pituitary Hormones in a Cohort of Pre-Rheumatoid Arthritis (pre-RA) Than in Non-RA Control (CN) Subjects
Abstract Number: 2381

Serum Level of IL-33 and Soluble ST2 and Their Association with Disease Activity in Patients with Behcet’s Disease
Abstract Number: 613

Serum Level of Syndecan-1 Is Associated with Disease Activity in Patients with Systemic Lupus Erythematosus
Abstract Number: 2280

Serum Metabolomics As a Novel Diagnostic Approach for Systemic Lupus Erythematosus
Abstract Number: 2248

Serum Phosphatidylserine-Specific Phospholipase A1 (PS-PLA1) Identified As a Novel Biomarker for Systemic Lupus Erythematosus (SLE)
Abstract Number: 652

Serum Rituximab Levels and Efficiency of B-Cell Depletion: Differences Between Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis
Abstract Number: 1916

Serum Uric Acid As a Biomarker for Mitigation of Infusion Reactions in Patients Treated with Pegloticase for Refractory Chronic Gout
Abstract Number: 167

Serum Uric Acid Control and Risk of Flare According to Different Cut-Offs in Patients with Gout: Longitudinal Analysis From the King Study of the Italian Society for Rheumatology
Abstract Number: 1174

Severe Adverse Events Associated with Use of Biologic Therapy in Juvenile Idiopathic Arthritis: A Single-Center Study
Abstract Number: 1369

Severe Joint Damage in Psoriatic Arthritis: Mutilans and Ankylosis
Abstract Number: 1053

Severe Joint Injury Assessed by Musculoskeletal Ultrasonography (MSKUS) Predicts the Presence of MRI-Proven Osteitis in Patients with Rheumatoid Arthritis
Abstract Number: 519

Sex-Specific Regulatory T Cell Dysfunction in a Mouse Model of Sjögren Syndrome
Abstract Number: 2422

Sexual Activity and Sexual Functioning Among Women with Systemic Sclerosis Compared to Women From a Population Sample
Abstract Number: 602

Sexual and Reproductive Health Counseling Among Adolescents with Systemic Lupus Erythematosus
Abstract Number: 2006

Sexual Health and Substance Abuse in Adolescents with Rheumatic Conditions
Abstract Number: 1445

Shared and Unique Molecular Features of Nephritis in 3 Models of Murine SLE
Abstract Number: 927

Shared Decision Making in Secondary Care: Rheumatologic Patient’s Perspective
Abstract Number: 939

Shared High Risk of Intensive Care Unit Admission in Three Autoimmune Inflammatory Diseases
Abstract Number: 1823

Short Periods of Glucocorticoid Use Increase the Risk of Gastrointestinal Bleeding
Abstract Number: 1666

Short Term Use of Glucocorticoids Is Not Associated with Acute Risk of Myocardial Infarction
Abstract Number: 2169

Short to Medium Term Safety of Glucocorticoid Therapy in Rheumatoid Arthritis: A Systematic Review and Dose-Response Analysis of Randomized Controlled Trials
Abstract Number: L12

Short- and Long-Term Efficacy of Tofacitinib, an Oral Janus Kinase Inhibitor, in the Treatment of Patients with Rheumatoid Arthritis and an Inadequate Response to TNF Inhibitors: Analyses of Pooled Phase 2, Phase 3, and Long-Term Extension Studies
Abstract Number: 1285

Short-Term Efficacy of Etanercept Plus Methotrexate Vs.Various Disease-Modifying Anti-Rheumatic Combinations with Methotrexate in Established Rheumatoid Arthritis
Abstract Number: 2023

Should Joint Ultrasound Contribute to Therapeutic Decisions in Juvenile Idiopathic Arthritis?
Abstract Number: 1549

Sibling Relative Risk and Heritability of Kawasaki Disease: A Nationwide Population Study in Taiwan
Abstract Number: 2673

Sibling Relative Risk and Heritability of Sjögren’s Syndrome: A Nationwide Population Study in Taiwan
Abstract Number: 755

Sifalimumab, an Anti-IFN-Alpha Monoclonal Antibody Shows Target Suppression of a Type I IFN Signature in Blood and Muscle of Dermatomyositis and Polymyositis Patients
Abstract Number: 1658

Signal Transducer and Activator of Transcription 3 Induced Synovial Invasion and Migration Is Mediated in Part Through the Notch/Hypoxia-Inducible Factor 1α Pathways
Abstract Number: 2276

Signature of Circulating Micro-RNA in Systemic Lupus Erythematosus
Abstract Number: 2105

Significant Correlation Between ACR/EULAR Remission Criteria and a Simplified Measure Using RAPID3 and Careful Joint Examination without a Formal Joint Count
Abstract Number: 219

Significant Functional Improvement Using Aggressive Immunomodulatory Therapy in Patients with Inflammatory Myopathy and Interstitial Lung Disease
Abstract Number: 326

Silencing Intraarticular Snail Expression Ameliorates Rat Collagen-Induced Arthritis Through Induction of Mesenchymal-Epithelial Transition in Synovial Fibroblasts
Abstract Number: 2214

Similar Levels of Disease Activity in Patients with Oligoarticular Vs. Polyarticular Peripheral Spondyloarthritis
Abstract Number: 2350

Similarities Exceeds Differences in the Pattern of Joint and Vascular Positron Emission/Computed Tomography Uptake in Polymyalgia Rheumatica and Giant Cell Arteritis
Abstract Number: 245

Similarities of Patient Self-Report Scores From a Multidimensional Health Assessment Questionnaire (MDHAQ), Laboratory Tests, Physician Global Assessment, and Polyarticular Involvement in Patients with Osteoarthritis and Rheumatoid Arthritis
Abstract Number: 552

Simple Questions in the Dermatology Office May Reasonably Exclude, but Do Not Reliably Identify Psoriatic Arthritis Patients: Results From the Center of Excellence for Psoriasis and Psoriatic Arthritis
Abstract Number: 228

Simultaneous Initiating of Glucocorticoids and disease-Modifying Antirheumatic Drug Therapy in Polymyositis and Dermatomyositis Patients Results in the Opportunity to Taper Dosage of Glucocorticoids Early
Abstract Number: 1508

Simvastatin Attenuates Pulmonary Fibrosis in a Murine Model of Systemic Sclerosis
Abstract Number: 2278

Single Nucleotide Polymorphisms (SNPs) of Integrin-á-M (ITGAM) Are Associated with Susceptibility to Systemic Lupus Erythematosus (SLE) in an Asian Lupus Cohort
Abstract Number: 412

Single Nucleotide Polymorphisms within the HLA-DRB1 Gene in Relation to Antibodies Against Citrullinated Peptides in Individuals Prior to the Development of Rheumatoid Arthritis
Abstract Number: 1431

Single Photon Emission Computed Tomography Contributes to Clinical Assessments in Neuropsychiatric Systemic Lupus Erythematosus Patients
Abstract Number: 437

SIRT6 Regulates Cigarette Smoke Induced MMP1 Expression in Rheumatoid Arthritis Synovial Fibroblasts
Abstract Number: 358

Six Months of an Attenuated Cobra Regimen (‘COBRA-light’) Is Clinically Noninferior to the Original Cobra Regimen: An Open-Label Randomized Trial in Early Rheumatoid Arthritis
Abstract Number: 1477

Skin Autofluorescence As a Measure of Oxidative Stress in Systemic Sclerosis Is Not Affected by Skin Thickness, Erythema or Melanin
Abstract Number: 2424

Sleep Disturbances in Systemic Sclerosis: Evidence for the Role of Gastrointestinal Symptoms, Pain, and Pruritus
Abstract Number: 1567

Sleep Study with Armband Device in Fibromyalgia Patients: Fibromyalgia Patients Don’t Rest Their Weary Muscles
Abstract Number: 425

Slug Is Induced by Benzo(a)Pyrene and EGF Through PI3K/Akt/mTOR Pathway and Is Closely Involved in the Regulation of the Invasive Properties of FLS in Rheumatoid Arthritis
Abstract Number: 251

Smaller Baseline and Follow-up Quadriceps Muscle Cross-Sectional Area Increases the Odds of Knee Replacement in Knee Osteoarthritis
Abstract Number: 95

Smoking Is Associated with Worse and More Widespread Pain, Worse Disease Activity, Function, Fatigue and Health Related Quality of Life in Patients with Axial Spondyloarthritis –Results From a Population Based Cohort
Abstract Number: 1828

Smoking Is Associated with Worse and More Widespread Pain, Worse Fatigue, General Health and Quality of Life in a Swedish Population Based Cohort of Patients with Psoriatic Arthritis
Abstract Number: 2139

Smoking Is Associated with Worsening Functional Status Over Time in a Diverse Cohort of Patients with Rheumatoid Arthritis
Abstract Number: 1187

Smoking Status Is Associated with Inflammatory Cytokine Profile and Disease Activity in Anti-Citrullinated Protein Antibody Positive Rheumatoid Arthritis: Decreased Inflammation and Disease Improvement with Smoking Cessation?
Abstract Number: 2574

Smoking, Autoantibodies and Vascular Events in Systemic Lupus Erythematosus
Abstract Number: 2524

Snapin Is Critical for the Maturation of Autophagosome and Phagosome in Macrophages
Abstract Number: 2504

SOCS1 Is One of the Key Molecules to Prevent the Plasticity of Regulatory T Cells and the Development of Autoimmunity
Abstract Number: 745

Soft Drink Intake and Progression of Radiographic Knee Osteoarthritis: Data From the Osteoarthritis Initiative
Abstract Number: 1239

Soluble Glycoprotein VI: A Novel Risk Marker for Thrombosis in Patients with Inflammatory Arthritis
Abstract Number: 2680

Soluble Receptor for Advanced Glycation End Products Alleviates Nephritis in NZB/WF1 Mice
Abstract Number: 617

Soluble Urokinase Plasminogen Activator Receptor (suPAR) Levels Reflect Organ Damage in Systemic Lupus Erythematosus
Abstract Number: 102

Sonographic Assessment of Normal Peripheral Joints: Evaluation According to Demographics Parameters
Abstract Number: 264

Specialized Footwear Decreases Medial Tibial Bone Mineral Density Over 48 Weeks in Knee Osteoarthritis
Abstract Number: 2347

Specificity of the New American College of Rheumatology/European League Against Rheumatism Classification Criteria for Polymyalgia Rheumatica in Comparison with the Former Ones : A Single Centre Study
Abstract Number: 1920

Spectrum of IgG4-Related Disease and Diagnostic Value of Serum IgG4 Determinations
Abstract Number: 1025

Spinal Inflammation in the Absence of SI Joint Inflammation On MRI in Patients with Active Non-Radiographic Axial Spondyloarthritis
Abstract Number: 1360

Spinal Involvement in Axial Psoriatic Artritis Is Not Determined by the Presence of HLA-B27. Is the HLA-B27 Arm of the Axial Spa Criteria Reliable for Classifying Axial Psoriatic Arthritis?
Abstract Number: 2222

Spinal Mobility Measures in Normal Individuals – the Mobility Study
Abstract Number: 778

Spinal MRI Has Little Incremental Diagnostic Value Compared with MRI of the Sacroiliac Joints Alone in Early Spondyloarthritis
Abstract Number: 1067

Spontaneous Aggregation of the Anti-Viral Mavs Protein in Certain Systemic Lupus Erythematosus Patients May Explain Excessive Type I Interferon Production
Abstract Number: 518

Spontaneous Sialadenitis Like Sjögren’s Syndrome in Orphan Nuclear Receptor γt (RORγt) Transgenic Mice
Abstract Number: 423

Sputa Autoantibodies in Patients with Established Rheumatoid Arthritis and Subjects At-Risk for Future Clinically Apparent Disease
Abstract Number: 1208

Stable Synovial Fluid Phenotype for Anti Citrullinated-Protein Antibodies in Established Rheumatoid Arthritis
Abstract Number: 515

Stages of Sjogren’s Syndrome Defined by Immune Mediators
Abstract Number: 2051

Standardized Data Collection Supports Reliable Reporting of Rheumatoid Arthritis (RA) Measures for the Medicare Physicians’ Quality Reporting System
Abstract Number: 224

Standardized Incidence Ratios and Predictors of Malignancies in 215 Southern Chinese Patients with Inflammatory Myopathies
Abstract Number: 2588

Standardized Patient Simulation Improves Internal Medicine Resident Musculoskeletal Examination Skills
Abstract Number: 310

STAT3 Plays a Central Role in NLRP3 Inflammasome-Mediated IL-1β Production and Pyronecrosis
Abstract Number: 1847

Status of the Rheumatology Clinical Trials Portfolio: Data From Clinicaltrials.Gov
Abstract Number: 376

Strategies for Use of Prednisolone in Rheumatoid Arthritis Have Changed Over the Past Decade: Data From the NOR-DMARD Register
Abstract Number: 19

Stress-Induced Cartilage Degradation Does Not Depend On NLRP3-Inflammasome in Osteoarthritis
Abstract Number: 1189

Stromal Cell Markers in the Synovial Tissue of Patients with Early Arthritis and Preclinical Rheumatoid Arthritis
Abstract Number: 256

Strontium Ranelate Decreases the Level of Urinary CTX-II in Patients with Knee Osteoarthritis
Abstract Number: 1596

Strontium Ranelate in Knee Osteoarthritis Trial (SEKOIA): A Structural and Symptomatic Efficacy
Abstract Number: 1011

Structural Damage Is Reduced by Early Achievement of Clinical Remission
Abstract Number: 591

Structural Progression of Ankylosing Spondylitis Associated with Elevation in Two NOVEL, Inflammatory Biomarkers; Matrix Metalloproteinase and Cathepsin-Derived
Abstract Number: 2130

Studies of Disease and Therapy-Response Biomarkers in Early Rheumatoid Arthritis Treated with Methotrexate
Abstract Number: 641

Study of Anti-Müllerian Hormone and Probability of Pregnancy in 112 Systemic Lupus Erythematosus Patients Exposed or Not to Cyclophosphamide
Abstract Number: 1205

Study of Association of CD40-CD154 Gene Polymorphisms with Disease Susceptibility and Cardiovascular Risk in Spanish Rheumatoid Arthritis Patients
Abstract Number: 1473

Sub-Analysis of ELF Score Biomarkers Components Indicates a Specific Correlation with Different Organ Involvement in Systemic Sclerosis
Abstract Number: 131

Subclinical Arthritis Visualised by Positron Emission Tomography and Macrophage Targeting Precedes Clinical Flare in Rheumatoid Arthritis Patients in DAS28 Remission
Abstract Number: 1257

Subclinical Atherosclerosis in Hispanic Patients with Rheumatoid Arthritis. Correlation with the Presence of Anti-Oxidized LDL Antibodies and Serum Levels of CD40L
Abstract Number: 462

Subcutaneous Abatacept: Long-Term Data From the Acquire Trial
Abstract Number: 829

Subcutaneous Nodules Are Significantly Associated with Cardiovascular Events in Patients with Rheumatoid Arthritis: Results From a Very Large US Registry
Abstract Number: 83

Substantial Functional Disability Is the Key Determinant of Discrepancies Between EQ-5D and SF-6D Utility Measures in Early Arthritis: Results From the Espoir Cohort
Abstract Number: 2379

Successful Treatment of Churg-Strauss Syndrome with Rituximab
Abstract Number: 651

Suicidal Ideation in Patients with Systemic Lupus Erythematosus: Incidence and Relationship with Anxiety/Depression Score Disease Activity and Organ Damage
Abstract Number: 2320

Superantigen Induces IL-17 Production From Extremely Polarized Th1 Clones
Abstract Number: 8

Supercharged Sox9 Protein Induces Chondrogenic Differentiation of Bone Marrow-Derived Mesenchymal Stem Cells
Abstract Number: 1741

Suppression of Glomerulonephritis in NZB/W F1 Mice by a Selective Inhibitor of Bruton’s Tyrosine Kinase (RN486)
Abstract Number: 2332

Suppression of PP2Ac Causes DNA Hypermethylation Through Enhanced Pmek/Perk Activity in T Cells
Abstract Number: 1761

Suppression of Rheumatoid Arthritis B Cells by XmAb5871, an Anti-CD19 Monoclonal Antibody That Co-Engages the B Cell Antigen Receptor and the FcγRIIb Inhibitory Receptor
Abstract Number: 2520

Suppressor of Cytokine Signaling 3 Is Reduced in Obese Patients with Osteoarthritis and Regulates Leptin Responses in Chondrocytes
Abstract Number: 724

Survival, Hospitalization or Need for Combination Therapy At One Year in Patients with Scleroderma-Associated Pulmonary Arterial Hypertension
Abstract Number: 448

Sustained and Cumulated Response Over Time in Rheumatoid Arthritis Patients Treated with Rituximab After Initial Failure of Anti Tumor Necrosis Factor Agents
Abstract Number: 1682

Sustained Clinical Remission (Disease Activity Score 28 <2.6) Protects for Cardiovascular Disease in Rheumatoid Arthritis Patients
Abstract Number: 827

Sustained Development of Cardiovascular Disease in Rheumatoid Arthritis Despite Cardioprotective Treatment: The 10-Year Prospective Carre-Study
Abstract Number: 2621

Sustained Disease Improvement and Safety Profile Over 1745 Patient-Year Experience (7 years) with Belimumab in Systemic Lupus Erythematosus Patients
Abstract Number: 1280

Sustained Efficacy Responses and a Consistent Safety Profile with Rituximab Repeat Treatment Over 5 Years in Patients with Rheumatoid Arthritis and an Inadequate Response to Tumour Necrosis Factor Inhibitors
Abstract Number: 2448

Sustained Improvement Physical Function Following an Integrated Rehabilitation Programme for Chronic Knee Pain
Abstract Number: 1864

Swimming Is As Effective As Walking for Treating Fibromyalgia: A Randomized Controlled Trial
Abstract Number: 2561

Switching Between TNF-Inhibitors in Psoriatic Arthritis: Data From the NOR-DMARD Study
Abstract Number: 968

Sympathetic Nervous System Dysfunction in Fibromyalgia and in Overlapping Central Sensitivity Syndromes. A Systematic Review of Controlled Studies
Abstract Number: 801

Symptom Improvement in Fibromyalgia Patients Is Related to Reduced Network Connectivity As Measured by EEG Coherence
Abstract Number: 40

Syndecan-4 Regulates Activation of WNT Signaling in Chondrocytes
Abstract Number: 1638

Synovial Fibroblast Migration Is Modulated by the Focal Contact Protein Lasp-1
Abstract Number: 248

Synovial Fluid Leptin Level Is Associated with Residual Pain and Functional Disability One Year After Total Joint Arthroplasty
Abstract Number: 1766

Synovial Gene Expression and Response to Rituximab: Preliminary Data
Abstract Number: 17

Synovial Overexpression of Wnt and Wnt-1-Induced Secreted Protein 1 Induces Cartilage Damage by Skewing of TGF-Beta Signaling and Reduction of the Anti-Hypertrophy Factor Sox9
Abstract Number: 2342

Synovial Tissue Analysis in the Pre-Clinical Phase of Arthritis: T-Cell Infiltration Preceding the Development of Arthritis
Abstract Number: 466

Synovialitis Plus Articular Cartilage Monitoring Via Magnetic Resonance Imaging and Ultrasound Under Tocilizumab Therapy in Patients with Rheumatoid Arthritis
Abstract Number: 46

Synovitis in Secondary Osteoarthritis Due to Rheumatoid Arthritis: A Proof-of-Concept Study
Abstract Number: 436

Synthetic Anti-CCP Antibody Aggravated Severity of Animal Arthritis and Captured Citrullinated Antigen in the Serum of Patients with Rheumatoid Arthritis
Abstract Number: 97

Systematic Review of Explanatory and Predictive Models in Rheumatology: Lack of Adhearance to Methodologic Standards
Abstract Number: 2240

Systematic Review of Skin Nontuberculous Mycobacteria Infection in Systemic Lupus Erythematosus: An Unusual Skin Infection Mimicking Lupus Vasculitis
Abstract Number: 1052

Systematic Review of the Association Between Magnetic Resonance Imaging and Radiographic Detection of Erosions in Rheumatoid Arthritis
Abstract Number: 1708

Systemic Lupus Erythematosus Cardiovascular Risk Equation
Abstract Number: 845

Systemic Lupus Erythematosus Immune Complexes Upregulate the Expression of CD319 and CD229 On Plasmacytoid Dendritic Cells
Abstract Number: 2285

Systemic Lupus Erythematosus RNA-Seq: Endogenous Retroviral Group K Overexpression in Monocytes
Abstract Number: 1491

Systemic Sclerosis – Effects of Agonistic Autoantibodies Directed Against the Angiotensin Receptor Type 1 and the Endothelin Receptor Type A On Effector Cells
Abstract Number: 722

Systemic Sclerosis Associated Pulmonary Hypertension – Is Pulmonary Veno-Occlusive Disease As Common As They Say?
Abstract Number: 853

Systemic Sclerosis Classification Criteria: Developing Methods for Multi-Criteria Decision Analysis
Abstract Number: 1523

Systemic Vasculitis and Pregnancy: a Multicenter Study On Maternal and Neonatal Outcome of 43 Prospectively Followed Pregnancies